New Antimicrobials News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from New antimicrobials. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In New Antimicrobials Today - Breaking & Trending Today

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript November 14, 2023 Acurx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.23952, expectations were $-0.28. Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief […] ....

United States , Kevin Garey , Dave Luci , Robert Deluccia , Bob Deluccia , Robert Shawah , Rob Shawah , David Luci , University Of Houston College Pharmacy , Microbial Resistance Congress , European Medicines Agency , International Conference On Molecular Biology , Exchange Commission , World Anti Microbial Resistance Congress , Executive Chairman , Gram Positive Bacterial Infections , Houston College , Principal Investigator , Gram Positive Selective Spectrum Activity , Secondary Analysis , New Antimicrobials , Gram Positive Bacterial , International Conference , Molecular Biology , Vitro Biofilm Studies , Comparator Antibiotics ,

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Rob Shawah , Ed Arce , Kevin Garey , Michael Okunewitch , Dave Luci , David Luci , Thomas Yip , Robert Deluccia , Jason Mccarthy , Robert Shawah , Bob Deluccia , International Conference On Molecular Biology , Exchange Commission , European Medicines Agency , University Of Houston College Pharmacy , Maxim Group , Microbial Resistance Congress , Acurx Pharmaceuticals Third Quarter , Acurx Pharmaceuticals Inc , Acurx Pharmaceuticals , Call Transcript November , Chief Financial , Executive Chairman , World Anti Microbial Resistance Congress , Gram Positive Bacterial Infections ,

Acurx Announces Ibezapolstat Scientific Posters and Presentations at ClostPath 2023 and IDWeek 2023 Scientific Conferences

Three scientific posters highlighting novel anti-virulence pharmacologic properties of oral ibezapolstat for C. difficile Infection; effects on toxin production, biofilm and the gut microbiomeA. ....

United States , Kevin Garey , Michael Silverman , Jinhee Jo , Robertj Deluccia , Eugenie Basseres , Society Or Healthcare Epidemiology Of America , Drug Administration , University Of Houston , Acurx Pharmaceuticals Inc , Medicine Association , Infectious Diseases Society Of America , Data Monitoring Committee , Company Ph , International Conference On Molecular Biology , Pediatric Infectious Diseases Society , Trial Oversight Committee , University Of Houston College Pharmacy , Society For Healthcare Epidemiology Of America , Infectious Disease Society Of America Idsa Idweek , Exchange Commission On Form , Acurx Pharmaceuticals , Society Of Infectious Diseases Pharmacists , Exchange Commission , School Of Pharmacy , New Class ,

AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023

AN2 Therapeutics to Present New Data for Epetraborole at IDWeek 2023
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United States , Paul Eckburg , Infectious Disease Society Of America Idsa Idweek , Therapeutics Inc , Group Study To Assess The Safety , Product Service , Present New Data , Infectious Disease Society , Chief Medical Officer , Novel Antibiotic , New Antimicrobials , Pipeline Part , Recent Mycobacterium , Broth Microdilution , Experimental Therapeutics , Parallel Group Study , Oral Epetraborole Tablets , Adult Subjects , Varying Degrees , Renal Function , Antimicrobial Novel Agents , Single Dose Study , Epetraborole Tablets , Alcohol Dehydrogenase , Healthy Japanese Adult Subjects , Activity Against Mycobacterium ,

CF AMR Syndicate Launches £3 million Collaborative Discovery Programme

CF AMR Syndicate Launches £3 million Collaborative Discovery Programme  Funding New Antimicrobials to Treat Lung Infections in People with Cystic Fibrosis  16 March 2023  Today (16 March 2023), Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) announces a £3 million Collabor. ....

Catherine Kettleborough , Beverley Isherwood , Paula Sommer , Collaborative Discovery Programme , Cf Syndicate , Head Of Research At Cystic Fibrosis , Cystic Fibrosis , Cystic Fibrosis Cf Syndicate In Antimicrobial Resistance , New Antimicrobials , Treat Lung Infections , Antimicrobial Resistance , Target Product Profiles , Medicines Discovery Catapult , Partnership Lead , Infectious Disease , Cystic Fibrosis Trust ,